Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
report source : Ir.akerotx.com save search
Akero Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
Published: 2023-03-17 (Crawled : 11:00) - ir.akerotx.com
AKRO | $20.76 1.22% 1.2% 790K
|
Health Technology
|
| O: 0.58%
H: 1.98%
C: 0.65%
year therapeutics financial results
Akero Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-04 (Crawled : 11:00) - ir.akerotx.com
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: 1.83%
H: 0.7%
C: -0.35%
AKRO | $20.76 1.22% 1.2% 790K
|
Health Technology
|
| O: -0.46%
H: 4.12%
C: -5.62%
therapeutics financial update results
Study Published in JHEP Reports Shows Efruxifermin Rapidly Improved Fibrosis in Cirrhotic NASH patients After 16 Weeks of Treatment
Published: 2022-08-24 (Crawled : 12:00) - ir.akerotx.com
AKRO | $20.76 1.22% 1.2% 790K
|
Health Technology
|
| O: 0.25%
H: 10.47%
C: 9.11%
treatment fibrosis nash study efruxifermin
Akero Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
Published: 2022-08-04 (Crawled : 21:00) - ir.akerotx.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.44%
H: 0.66%
C: -0.75%
HTGC F | $18.46 1.15% 0.38% 660K
|
Finance
|
| O: 0.13%
H: 2.69%
C: 2.69%
AKRO | $20.76 1.22% 1.2% 790K
|
Health Technology
|
| O: 1.33%
H: 6.94%
C: 6.33%
therapeutics update results
Akero Therapeutics Reports First Quarter 2022 Financial Results
Published: 2022-05-06 (Crawled : 16:20) - ir.akerotx.com
AKRO | $20.76 1.22% 1.2% 790K
|
Health Technology
|
| O: -4.21%
H: 0.0%
C: 0.0%
therapeutics results
Akero Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
Published: 2021-11-12 (Crawled : 00:20) - ir.akerotx.com
AKRO | $20.76 1.22% 1.2% 790K
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
financial results results
Akero Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
Published: 2021-05-13 (Crawled : 11:00) - ir.akerotx.com
AKRO | $20.76 1.22% 1.2% 790K
|
Health Technology
|
| O: 0.04%
H: 2.33%
C: 0.8%
financial results results
Akero Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
Published: 2021-03-16 (Crawled : 12:00) - ir.akerotx.com
AKRO | $20.76 1.22% 1.2% 790K
|
Health Technology
|
| O: -0.91%
H: 0.0%
C: -2.85%
financial results results
Akero Therapeutics Reports Third Quarter 2020 Financial Results
Published: 2020-11-12 (Crawled : 15:25) - ir.akerotx.com
AKRO | $20.76 1.22% 1.2% 790K
|
Health Technology
|
| O: 6.86%
H: 0.0%
C: -9.97%
financial results results therapeutics
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.